Research source
AI helped predict kidney disease progression to guide better care choices and reduce costs.
Based on Cost-effectiveness analysis of a prognostic risk assessment for early-stage 1-3b diabetic kidney disease patients in the United States
Published by Cost Effectiveness and Resource AllocationJun 24, 2026
Peer-reviewed paperMedium evidenceComputational study
What researchers observed
The study analyzed cost-effectiveness of AI risk scores versus traditional methods for early diabetic kidney disease in US Medicare patients.
What this could mean
This could help researchers better select patients who need early treatments and plan cost-effective care studies for kidney disease.
What researchers still need to learn
Researchers still need to learn whether KidneyIntelX improves patient health outcomes beyond model predictions in real-world care.